Alyeska Investment Group’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,078,413
Closed -$14.2M 693
2023
Q3
$14.2M Hold
1,078,413
0.1% 244
2023
Q2
$13.6M Hold
1,078,413
0.1% 237
2023
Q1
$14.1M Buy
1,078,413
+225,913
+27% +$3.66M 0.12% 208
2022
Q4
$15M Buy
852,500
+77,500
+10% +$1.3M 0.16% 176
2022
Q3
$11.8M Buy
775,000
+50,000
+7% +$809K 0.14% 187
2022
Q2
$10.8M Buy
725,000
+200,000
+38% +$3.74M 0.12% 202
2022
Q1
$11.8M Buy
+525,000
New +$10.6M 0.13% 188

Other funds holding MDRX

Alyeska Investment Group's MDRX Position: Q4 2023 in Review

Alyeska Investment Group sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2023, closing a stake of 1,078,413 shares — an estimated $14.2M sold.

Alyeska Investment Group first reported a position in MDRX in Q1 2022 and held it in 7 quarters. The position peaked at $15M in Q4 2022. 225 funds tracked by Wall St. Rank hold MDRX as of Q4 2023.

  • Alyeska Investment Group reported no remaining Veradigm Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 1,078,413 Veradigm Inc. Common Stock shares in Q4 2023, an estimated $14.2M.
  • Alyeska Investment Group first reported a position in Veradigm Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Alyeska Investment Group's Veradigm Inc. Common Stock position peaked at $15M in Q4 2022.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.